These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6338164)

  • 1. Megadose steroids in severe head injury. Results of a prospective double-blind clinical trial.
    Braakman R; Schouten HJ; Blaauw-van Dishoeck M; Minderhoud JM
    J Neurosurg; 1983 Mar; 58(3):326-30. PubMed ID: 6338164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high-dose dexamethasone on outcome from severe head injury.
    Dearden NM; Gibson JS; McDowall DG; Gibson RM; Cameron MM
    J Neurosurg; 1986 Jan; 64(1):81-8. PubMed ID: 3510286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone and severe head injury. A prospective double-blind study.
    Cooper PR; Moody S; Clark WK; Kirkpatrick J; Maravilla K; Gould AL; Drane W
    J Neurosurg; 1979 Sep; 51(3):307-16. PubMed ID: 381599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Ultrahigh" dexamethasone in acute brain injury. Results from a prospective randomized double-blind multicenter trial (GUDHIS). German Ultrahigh Dexamethasone Head Injury Study Group.
    Gaab MR; Trost HA; Alcantara A; Karimi-Nejad A; Moskopp D; Schultheiss R; Bock WJ; Piek J; Klinge H; Scheil F
    Zentralbl Neurochir; 1994; 55(3):135-43. PubMed ID: 7810251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial.
    Firsching R; Piek J; Skalej M; Rohde V; Schmidt U; Striggow F;
    J Neurol Surg A Cent Eur Neurosurg; 2012 Aug; 73(4):204-16. PubMed ID: 22696266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of high dose dexamethasone in the treatment of acute stroke.
    Ogun SA; Odusote KA
    West Afr J Med; 2001; 20(1):1-6. PubMed ID: 11505880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ultra-high, short-term dexamethasone therapy in craniocerebral trauma. Rationale and design of a multicenter study].
    Gaab MR; Dietz H
    Neurochirurgia (Stuttg); 1989 Jul; 32(4):93-100. PubMed ID: 2671769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of high dose dexamethasone in children with severe closed head injury. A preliminary report.
    James HE; Madauss WC; Tibbs PA; McCloskey JJ; Bean JR
    Acta Neurochir (Wien); 1979; 45(3-4):225-36. PubMed ID: 371348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral dexamethasone for the treatment of pain in children with acute pharyngitis: a randomized, double-blind, placebo-controlled trial.
    Bulloch B; Kabani A; Tenenbein M
    Ann Emerg Med; 2003 May; 41(5):601-8. PubMed ID: 12712025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroids in severe head injury: A prospective randomized clinical trial.
    Saul TG; Ducker TB; Salcman M; Carro E
    J Neurosurg; 1981 May; 54(5):596-600. PubMed ID: 7014790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial.
    Temkin NR; Anderson GD; Winn HR; Ellenbogen RG; Britz GW; Schuster J; Lucas T; Newell DW; Mansfield PN; Machamer JE; Barber J; Dikmen SS
    Lancet Neurol; 2007 Jan; 6(1):29-38. PubMed ID: 17166799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group.
    Marmarou A; Nichols J; Burgess J; Newell D; Troha J; Burnham D; Pitts L
    J Neurotrauma; 1999 Jun; 16(6):431-44. PubMed ID: 10391361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment results in severe craniocerebral trauma with and without dexamethasone therapy].
    Sollmann WP; Hussein S; Stolke D
    Neurochirurgia (Stuttg); 1985 Mar; 28(2):46-50. PubMed ID: 3990889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of respiratory distress syndrome after prenatal dexamethasone treatment.
    Taeusch HW; Frigoletto F; Kitzmiller J; Avery ME; Hehre A; Fromm B; Lawson E; Neff RK
    Pediatrics; 1979 Jan; 63(1):64-72. PubMed ID: 375171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures.
    Young B; Rapp RP; Norton JA; Haack D; Tibbs PA; Bean JR
    J Neurosurg; 1983 Feb; 58(2):231-5. PubMed ID: 6848680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
    Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
    Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone.
    Hoffman SL; Punjabi NH; Kumala S; Moechtar MA; Pulungsih SP; Rivai AR; Rockhill RC; Woodward TE; Loedin AA
    N Engl J Med; 1984 Jan; 310(2):82-8. PubMed ID: 6361558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A precursor of phospholipids in the treatment of severe traumatic comas].
    Cohadon F; Richer E; Poletto B
    Neurochirurgie; 1982; 28(4):287-90. PubMed ID: 6759958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries. Executive Committee of the International Selfotel Trial.
    Morris GF; Juul N; Marshall SB; Benedict B; Marshall LF
    Neurosurgery; 1998 Dec; 43(6):1369-72; discussion 1372-4. PubMed ID: 9848851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.